| 38.55 Data as of May 23 |  +1.85 / +5.04%Today’s Change | 11.00 Today|||52-Week Range 39.34 | +105.60% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $1.1B |
Puma Biotechnology, Inc. 10880 Wilshire Boulevard Los Angeles California 90024 |
| Other institutional | 42.47% |
| Individual stakeholders | 32.92% |
| Mutual fund holders | 31.62% |
| Alan H. Auerbach | Chairman, President & Chief Executive Officer |
| Charles R. Eyler, MBA | Treasurer & Senior Vice President-Administration |
| Richard Paul Bryce, MD | Senior VP-Clinical Research & Development |
| Mariann Ohanesian | Senior Director-Investor Relations |
| Richard Benton Phillips, PhD | Senior VP-Regulatory Affairs & Quality Assurance |
.
